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E-mail address: smzhou@ieee.org (S.-M. Zhou).It has been often demonstrated that clinicians exhibit both inter-expert and intra-expert variability when
making difﬁcult decisions. In contrast, the vast majority of computerized models that aim to provide
automated support for such decisions do not explicitly recognize or replicate this variability. Further-
more, the perfect consistency of computerized models is often presented as a de facto beneﬁt. In this
paper, we describe a novel approach to incorporate variability within a fuzzy inference system using
non-stationary fuzzy sets in order to replicate human variability. We apply our approach to a decision
problem concerning the recommendation of post-operative breast cancer treatment; speciﬁcally,
whether or not to administer chemotherapy based on assessment of ﬁve clinical variables: NPI (the Not-
tingham Prognostic Index), estrogen receptor status, vascular invasion, age and lymph node status. In
doing so, we explore whether such explicit modeling of variability provides any performance advantage
over a more conventional fuzzy approach, when tested on a set of 1310 unselected cases collected over a
fourteen year period at the Nottingham University Hospitals NHS Trust, UK. The experimental results
show that the standard fuzzy inference system (that does not model variability) achieves overall agree-
ment to clinical practice around 84.6% (95% CI: 84.1–84.9%), while the non-stationary fuzzy model can
signiﬁcantly increase performance to around 88.1% (95% CI: 88.0–88.2%), p < 0.001. We conclude that
non-stationary fuzzy models provide a valuable new approach that may be applied to clinical decision
support systems in any application domain.
 2012 Elsevier Inc. All rights reserved.1. Introduction
It is known that medical and health reasoning is inherently
uncertain [1]. Doctors and nurses often ﬁnd it difﬁcult to reach
an unequivocal decision for a number of reasons. The data may
(will) be inaccurate and imprecise, knowledge may be uncertain
and the linguistic terms used to express the decision may be vague.
Traditional modeling techniques are not always suitable for deal-
ing with human knowledge and reasoning involving uncertainty.
In contrast, fuzzy sets and fuzzy logic have proven to be able to
transfer human knowledge into computer manageable models
using linguistic terms. Fuzzy inference systems (also known as fuz-
zy rule based system, fuzzy expert systems, fuzzy models, fuzzy lo-
gic systems, etc. [2]) use a number of ‘if–then’ rules to perform
non-linear mappings from input space to output space. As they
are based on explicit ‘if–then’ rules featuring linguistic terms, fuzzy
systems usually have good interpretability [3]. These ‘if–then’ rulesll rights reserved.are the heart of a fuzzy inference system. Fuzzy rules are normally
obtained from knowledge extracted from ‘experts’ [4,5] or ex-
tracted from real-world datasets [7]. However, generating a fuzzy
model with optimal (or even just acceptable) performance can of-
ten be quite difﬁcult, especially in safety-critical contexts such as
biomedical domains [8,9].
On the other hand, from the perspective of health informatics,
an important way in which computer scientists assist healthcare
providers in making decisions is to develop mathematical models
with good predictive performance [9]. Even modest improvements
in the predictive performance of mathematical models can greatly
beneﬁt patients and healthcare providers. For example, in 1994, it
was estimated that just one-percent accuracy improvement in the
accuracy of predicting pneumonia outcomes and hospital admis-
sions of pneumonia patients could save about 90 million dollars
in healthcare costs per year in the United States [10]. Hence
improving model prediction performance is of real interest in med-
ical and health care research.
Many techniques have been developed to tune fuzzy models in
order to obtain optimal prediction performance. For example,
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pert system to validate and interpret umbilical cord blood acid–
base status [11], such that the correlation between the tuned fuzzy
model and clinicians was higher than between the clinicians them-
selves. Lee et al. [12] proposed a fuzzy neural network model
which is able to tune the shape of antecedent linguistic terms, rule
importance degrees and linguistic term importance. A nonlinear
function was used to evaluate the proposed method, which dem-
onstrated good results [12]. The Adaptive-Network-based Fuzzy
Inference System (ANFIS) developed by Jang [1] is a well known
fuzzy model tuning method. In general, there are two key steps
in building an ANFIS model. The ﬁrst step is to construct fuzzy sets
used to describe different fuzzy rules. The second step is to opti-
mize rule parameters by using a hybrid method which combines
gradient descent and a least squares approach. The ANFIS method
has been widely used in various applications, such as [13–16].
However, these conventional fuzzy model tuning methods focus
only on improving global model accuracy without consideration
of preserving model interpretability, two conﬂicting modeling
objectives [3,17].
Breast cancer is the most common cancer found in women in
the United Kingdom and accounts for almost one in three of all
cancers. In 2005, over 45,000 women were diagnosed with breast
cancer. More than 12,000 women die from breast cancer every year
[18]. In light of this, it is vital to select the proper course of treat-
ment once a diagnosis has been made. However, this is a very dif-
ﬁcult and complex procedure. In many countries, in order to
achieve optimal treatment, a multidisciplinary team (MDT) con-
sisting of oncologists, radiologists, pathologists and surgeons
meets to make treatment decisions [19,20]. During a meeting, all
members of the MDT discuss each patient case individually. Nor-
mally there is a meeting coordinator to collect case-notes, radio-
graphs and pathology reports to facilitate the meeting [21].
Inevitably there are many uncertain and imprecise terms used dur-
ing MDT discussions and decision making. Therefore a fuzzy model
is an obvious choice to simulate human decision making in breast
cancer.
Pena-Reyes and Sipper developed a fuzzy-genetic method ap-
plied to the Wisconsin breast cancer diagnosis data which gener-
ated a complete fuzzy inference system [8]. A neuro-fuzzy
decision model was proposed for prognosis of breast cancer relapse
in 2003 [22], in which the pathological data was provided by the
oncology service of the University Hospital of Malaga. This model
ﬁrstly used a fuzzy system as a ﬁlter to eliminate patients whose
clinical parameters did not comply with speciﬁed criteria, then a
back-propagation artiﬁcial neural network was applied to the out-
put of fuzzy system. Finally a threshold unit was used to group the
output from the network into ‘relapse’ and ‘non relapse’ groups.
Recently, a hybrid method of genetic algorithm and artiﬁcial im-
mune system was developed to generate various fuzzy inference
system parameters, based on a database of training cases, and this
was tested on the Wisconsin breast cancer diagnosis problem [23].
The results showed that the fuzzy inference system produced from
the hybrid algorithm reached the maximum classiﬁcation before
either the genetic algorithm or artiﬁcial immune system
individually.
However, in clinical and health decision making, it has been of-
ten demonstrated that variation may occur among a panel of hu-
man experts (inter-expert variability) and within an individual
expert over time (intra-expert variability) when facing with the
same problem (e.g. the same patient). The reasons behind this var-
iation might be that doctors and nurses gain more knowledge and
experience whilst serving on the multidisciplinary panel or simply
attributable to changes in the expert’s mood or physical state (e.g.
tiredness or stress) at the time of making the decision. Variability
in clinical treatment of breast cancer has been well documented.For example, Gort et al reported large variations in breast conserv-
ing surgery between hospitals, with rates ranging from 25.5% to
79.3% for small tumors (<2 cm) [34], while Bueno-de-Mesquita
et al reported that 14% of patients would have been given different
clinical risk and treatment advice based on the Nottingham prog-
nostic index value derived from discordant original pathological
evaluations [35]. However, such variability is often ignored in most
modeling techniques, including most fuzzy system design.
The concept of a ‘‘non-stationary fuzzy set’’ has recently been
proposed to explicitly model variation in uncertainty [24–27].
The membership function of a non-stationary fuzzy set is allowed
to be altered over time. A fuzzy inference system built upon such
non-stationary sets will then exhibit variability in the decisions ob-
tained. The various decisions obtained may be viewed as a set of
potentially acceptable alternative decisions, such as those obtained
from a panel of experts. Subsequently, ensemble and consensus
methods may be employed to obtain or recommend the best op-
tion from the set of acceptable alternatives, or may be used to ex-
plore the acceptable decision boundaries for a particular case.
While the variation in non-stationary fuzzy sets may be generated
randomly (as in this paper), this is by no means necessary. Further,
the use of random variations in the fuzzy sets to model expert var-
iability does not imply that we assume that the expert variation is
itself random.
In this paper, we create a fuzzy inference systemwith twelve if–
then fuzzy rules to implement the clinical post-operative treatment
recommendation protocol for breast cancer used by the doctors in
the Nottingham University Hospitals NHS Trust. A non-stationary
fuzzy inference system with explicit representation of variability
is then implemented to simulate human decision making in this
context and to explore whether the incorporation of variability is
of beneﬁt. A set of 1310 breast cancer cases are used to evaluate
the performance of various conﬁgurations of the non-stationary
fuzzy inference system, in comparison with the system without
variability and a conventional ANFIS approach. The layout of the
paper is as follows. Section 2 provides background on non-stationary
fuzzy sets and illustrates their use in a simple example. Section 3
provides a detailed description of the general clinical problem,
the speciﬁc clinical guidelines being modeled and the data. Section
4 describes the methods used including the design of the original
fuzzy inference system, the variability models and the alternative
ANFIS approach. The results of the evaluation experiments are then
presented, followed by discussion of our ﬁndings. Finally, the con-
clusions and some areas of potential future work are provided.2. Background
In this section, we introduce the concept of non-stationary fuz-
zy sets with an example.
2.1. Non-stationary fuzzy sets
Non-stationary fuzzy sets have membership functions that
change with time. _A is a non-stationary fuzzy set over a universe
of discourse X with membership function l _Aðx; tÞ, where
x 2 X; lx;t_A 2 ½0;1, and t refers to the time at which the fuzzy set
is instantiated. We let A be the underlying standard fuzzy set with
l _AðxÞ as it is the membership function. A is an instantiation of _A for
each time t. The non-stationary fuzzy set _A can be denoted by
_A ¼
Z
t2T
Z
x2X
l _Aðx; tÞ=x=t
Now we introduce a perturbation function f(t) to adjust the
standard membership function l _AðxÞ. In theory, f(t) could be a true
random function, following (for example) a normal distribution,
(a) underlying membership functions 
(b) multiple instantiations 
Fig. 2. An example of non-stationary fuzzy sets.
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instance, a sinusoidal function f(t) = sin(xt). l _Aðx; tÞSo we now
introduce the parameters of l _AðxÞ as p1, p2, . . . , pm, so if we express
l _Aðx; tÞ ¼ l _Aðx;p1ðtÞ; . . .pmðtÞÞ;
then pi(t) = pi + kifi(t), where i = 1, . . . ,m. This means that each time
each parameter is varied by a perturbation function multiplied by a
constant.
A non-stationary fuzzy inference system (FIS) is shown in Fig. 1.
A non-stationary FIS is a normal FIS that is run n times (i.e. n
instantiations of an ordinary FIS).
2.2. Illustration of non-stationary fuzzy sets
Fig. 2 shows an example of a non-stationary fuzzy set. Fig. 2a
illustrates a linguistic variable containing two standard mem-
bership functions mf1 and mf2. The parameters for mf1 are the
left-point, centre-point and right-point of the triangle (0, 3,
and 6, respectively). This can be expressed as lmf1(x, p1, p2, p3) =
lmf1(x, 0, 3, 6). The corresponding non-stationary membership of
mf1 is lmfiðx; tÞ ¼ l _Aðx; p1ðtÞ; p2ðtÞ; p3ðtÞÞ, with parameters
p1ðtÞ ¼ 0þ k1f1ðtÞ;
p2ðtÞ ¼ 3þ k2f2ðtÞ;
p3ðtÞ ¼ 6þ k3f3ðtÞ;
where [0, 10] is the universe of discourse. The perturbation func-
tions f1(t) = f2(t) = f3(t) = f(t) and k1 = k2 = k3 = k are used. In Fig. 2b,
f(t) is a normal distribution with mean of zero and standard devia-
tion r = 0.02, k = 1 and n, the number of iterations, is 10.
3. The clinical problems
3.1. Description of the clinical problem
The subsequent treatment for breast cancer following primary
treatment (normally surgery) is called adjuvant therapy, and is
used to reduce the chance of cancer reoccurrence. The adjuvant
therapy treatment may include hormone (anti-estrogen) therapy,
radiotherapy, chemotherapy, biological therapy, further operation
and clinical follow-up, or any combination of these [28,29].
The decisions regarding the recommended course of adjuvant
treatment are normally made during multi-disciplinary team
(MDT) meetings. The clinical procedure employed for recording
the data can be summarized by the following steps:
 the attribute information and additional comments related to
each patient’s treatment are recorded on a form;
 the forms are discussed by the various clinicians present during
the multi-disciplinary meeting and a further course of action is
agreed; andFig. 1. An outline of a non-stationary fuzzy inference system. after the meeting, the forms are collected and sent to a data
analyst for entry into a computer database.
The central aim of this paper is to design a computerized rule-
based model capable of simulating this process and reproducing
the speciﬁc recommendation for the administration of chemother-
apy (only). As there is no ‘gold-standard’ for the selection of adju-
vant therapy and many factors that complicate the assessment of
whether any particular decision was appropriate for the given pa-
tient (such as whether the patient subsequently complies with any
treatment recommendation), in this study we compared the out-
put of the automated system against the initial recommendation
of treatment agreed by the MDT. Thus, we are assessing whether
we can model the decision making process of the MDT, and are
not assessing the effect of the chemotherapy recommendation
and/or the actual adjuvant therapy administered in practice.3.2. Clinical guidelines
At Nottingham, the clinicians have developed a written protocol
for breast cancer treatment decisions that is routinely used for pa-
tients, as reproduced verbatim in Table 1. It can be seen from the
guidelines that, while the recommendation for hormone therapy
is straight-forward, the recommendation for or against chemother-
apy is a complex decision based on several factors, which are com-
bined in an unspeciﬁed manner. It can also be seen that several of
these factors have clear (crisp) decision boundaries, such as
‘Age < 40’, but in real world applications these boundaries are
likely to be vague. As examples, ﬁrstly, although the guidelines
for patients with NPI > 4.4 and ER positive status feature crisp
Table 1
The Nottingham University Hospitals NHS Trust clinical guidelines for adjuvant
therapy following surgery (reproduced verbatim).
NPI < 3.0 None
NPI 3.1–3.4
ER +ve Recommend hormone therapy
ER ve Recommend chemotherapy if VI
NPI 3.4–4.4
ER +ve Recommend hormone therapy
ER ve Recommend chemotherapy
NPI > 4.4
ER +ve Discuss chemotherapy
Consider
Recommending chemotherapy
Age <40
VI
HER-2 +ve
Weak ER(< 100/300)
Recommending Against Chemotherapy
Age >60
Only 1 LN positive
Special type cancer
ER -ve Recommend Chemotherapy
ER +ve: ER is positive.
ER ve: ER is negative.
Age: in years.
HER-2: Human Epidermal growth factor Receptor 2.
VI (Vascular Invasion): presence of unequivocal tumor in vascular spaces.
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dation should be between these ages; secondly, the NPI boundary
at 3.4 is clearly ambiguous in the ranges 3.1–3.4 and 3.4–4.4. Fuzzy
sets can be a very good choice for dealing with such vagueness.
Consequently, it was decided to attempt to design a fuzzy rule-
based system to model the recommendation of chemotherapy
(model output) based on the factors (model inputs) featuring in
the protocol.
It is a challenging task to induce trustworthy if–then rules in
designing a fuzzy recommendation system. Currently there are
two existing approaches for this task. One is to generate fuzzy rules
according to domain experts’ knowledge [4,5], the other is to in-
duce fuzzy rules from real-world datasets [6,7]. The fuzzy rules
generated from experts’ knowledge possess good interpretability,
but the system predication ability cannot always be guaranteed.
The advantage of data driven rule induction approaches lies in that
more speciﬁc knowledge characterized by trained fuzzy sets can be
generated with high model prediction accuracy. Given that ma-
chine learning algorithms used to derive fuzzy models from data
are usually accuracy-oriented, the fuzzy rules which are automat-
ically induced from datasets may lose interpretability [3,17], as
model accuracy and model interpretability are usually two con-
ﬂicting modeling objectives. In this paper, we employ the ﬁrst ap-
proach to generate fuzzy rules according to the written clinical
protocol.3.3. Description of raw and processed study data
The data involved in this study is a set of real world clinical
data concerning post-operative breast cancer treatment that was
kindly provided by The Nottingham Breast Institute (within the
Nottingham University Hospitals NHS Trust). This is a set of
post-operative data collected from a total of 8704 patients who
had all undergone some form of breast cancer operation (e.g.
wide local excision, auxiliary node clearance or sample) over a
27 year period from September 1982 to August 2009. The data
is comprized of a set of attributes examined on each patient’s
post-operative visit and adjuvant therapy treatment decision.
The attributes present in the data include: Encrypted patient identiﬁcation code, date of birth, visit and
diagnosis date.
 Invasive carcinoma size, grade, type and margins. Invasive
carcinoma describes the cancer that has already broken
through the layer of cells where it started (as opposed to
carcinoma in situ). Invasive carcinomas are potentially
life-threatening, and even with appropriate treatment not
everyone will be cured.
 Ductal Carcinoma In Situ (DCIS) size, grade, type and margins.
DCIS means that the cancer cells remain conﬁned inside the
ducts but have not grown into (invaded) deeper tissues in
the breast or spread to other organs in the body at the early
stage of cancer. Carcinoma in situ of the breast is some-
times referred to as non-invasive or pre-invasive breast
cancer.
 Whole tumor size (in mm).
 Nottingham Prognostic Index (NPI) value. The NPI was devel-
oped to help prognosis following surgery for breast cancer
as an attempt at using some fairly objective parameters to
determine the odds that a newly diagnosed case of invasive
ductal adenocarcinoma would beneﬁt from adjuvant che-
motherapy. The NPI value is calculated in terms of three
pathological criteria: the size of the lesion; the number of
involved lymph nodes; and the grade of the tumor.
 Estrogen Receptor (ER) test result. Estrogen receptor is a pro-
tein molecule found inside cells that are targets for estro-
gen action. The ER status tests show whether or not one
or both of those hormones fuel the tumor. Hormone sensi-
tive cancer grows slower than hormone negative cancer, so
it would beneﬁt from hormone-suppression treatment.
Hormone negative cancer responds to other types of treat-
ment rather than hormone-suppression.
 Progesterone Receptor (PR) test result. The progesterone
receptor is an estrogen-regulated protein. The expression
of PR determination indicates a responsive ER pathway,
so it could predict likely response to endocrine therapy in
breast cancer. For example, PR positive cancer would
respond well to hormone suppression treatments.
 Vascular Invasion (VI) test result. Breast cancer will go into
the channels, like the lymph channels, blood channels, par-
ticularly the venous system before it spreads to the rest of
the body. VI tests show whether or not the tumor cells have
acquired the ability to invade the walls of these channels
and may spread to the lymph nodes or beyond. VI is deter-
mined according to guidelines of the Royal College of
Pathologists [30] as a categorical variable.
 Lymph node stage, the number of positive lymph nodes (LN)
found from samples. Lymph nodes throughout the body
are an important part of human immune system. The clin-
ical signiﬁcance of lymph nodes lies in that they become
inﬂamed or enlarged in various conditions such as cancers,
so it can be used for cancer staging to determine the prog-
nosis and choose the treatment.
Several challenges arise in this study due to the clinical proce-
dures for recording the information. For example, the data consists
of the input from a number of different data analysts over the per-
iod and, because there is no standardized format for data entry,
inconsistencies in data formats can often occur. In addition, the
treatment decisions are not separately identiﬁed in their own data
ﬁeld and are, instead, hidden within a free-text comment ﬁeld. The
processing of the data is further complicated by the fact that differ-
ent treatment decisions may be identiﬁed through different nota-
tions or spellings. Furthermore, there can be missing values for
some attributes. This affects the clarity of the data and complicates
automatic classiﬁcation. All patient IDs were encoded (translated
Table 2
Description of continuous variables.
Continuous variable Median Range
NPI 3.56 2.04–10.00
ER 180 0–300
Age 59 26–88
LN positive 0 0–40
LN removed 5 0–43
ln ratio 0.00 0.00–1.00
Table 3
Description of categorical variables.
Categorical variable Number (percentage) of patients within each category
No Maybe Yes
VI 876 (66.9%) 112 (8.5%) 322 (24.6%)
Chemo 1067 (81.5%) 52 (4.0%) 191 (14.6%)
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correspondence analysis of patients, but not permitting actual
identiﬁcation. All necessary ethical permissions were obtained.
From Table 1, there are seven factors that feature in the recom-
mendation of chemotherapy: NPI, ER, VI, age of patient (Age),
lymph node (LN) status, HER-2 (Human Epidermal growth factor
Receptor 2) status and ‘Special type cancer’. Of these, we deter-
mined the ﬁve variables, NPI, ER, VI, Age and LN to be necessary
as inputs to the fuzzy system. While lymph node involvement is
incorporated into the NPI variable, the clinical protocol clearly uti-
lizes the LN feature itself separately from, and in conjunction with,
NPI. While this may mean that the clinical protocol over-repre-
sents lymph node involvement, and that the protocol incorporates
a subtle correlation between NPI and LN, this ‘dual-involvement’ of
LN is maintained in the fuzzy model. By doing so, the fuzzy model
has a direct correspondence to the clinical protocol (compare Ta-
bles 1 and 4). Whether this is a desirable or clinically justiﬁed fea-
ture of the protocol in use at Nottingham is outside the scope of
this paper.
HER-2 status had been relatively recently introduced into the
clinical guidelines (in 2007) and so most patients had no HER-2
status recorded. We decided to consider only those patients as-
sessed without the inclusion of HER-2 status into the clinical
guidelines. That is, the selected patients includes both HER-2 posi-
tive and negative patients who (historically) had been assessed by
the MDT prior to HER-2 status being available and, thus, before
having any effect on the decision process. Similarly, for any patient
without a recorded HER-2 status, this clearly cannot have been ta-
ken into account by the MDT, and so cannot have inﬂuenced the
recommendation. So, any patient with HER-2 status recorded
(whether positive or negative) was eliminated from the data. The
‘‘Special type cancer’’ feature was neither generally available nor
clearly described in the given dataset. Further, we could identify
no clearly articulated rules as to how the ‘special type’ of cancer
inﬂuenced decision making. Consequently, we decided to ignore
this variable within the decision model. While clearly unsatisfac-
tory, the elimination of this feature within the model may simply
lead to a reduction in the maximum overall model accuracy that
may be achieved. In effect, the feature becomes a ‘hidden variable’
which may affect the decision making of the MDT in clinical prac-
tice, but which our model does not include.
The output chemotherapy variable was determined by analysis
of the free-text comment ﬁeld of the raw data base. Speciﬁcally,
only a clear indication of chemotherapy was taken, although this
manifested in several forms. For example, textual entries of ‘Chemo
Yes’, ‘Chemo+’, ‘Advise Chemo’, etc., were translated to chemother-
apy ‘Yes’, while entries of ‘Chemo No’, ‘Advise no Chemo’, etc., were
translated as ‘No’, and entries speciﬁcally indicating ‘Discuss Che-
mo’ or ‘Consider Chemo’ were translated as ‘Maybe’. Any patient
record with no clear indication of chemotherapy recommendation
was not selected.
Only those cases having complete clinical records for these ﬁve
critical variables, without recorded HER-2 status, and with a che-
motherapy recommendation were retained, leading to a total sam-
ple of 1310 patients spanning a fourteen year period from July
1993 to March 2007. The patients were otherwise unselected—
i.e. all patients who matched these criteria were selected. While
clearly the elimination of any patient with missing information
may (technically) introduce bias into the study, this limitation is
not considered to be critical for the following reason. If the recom-
mendation produced by the fuzzy model was being assessed for
‘correctness’ against a ‘gold-standard’ or against patient outcomes
(survival times, etc.) in some manner, then this bias could affect
such assessment. However, given that the model recommendation
is compared only against the MDT recommendation, the reader
should simply bear in mind that the accuracies reported in theresults are all ‘when all features are present’. We make no claims
for the model accuracy in the absence of any input features. The
clinical guidelines for chemotherapy at Nottingham (with the
exception of HER-2 status as previously described) remained the
same over this period (July 1993–March 2007).
3.4. Input and output variable description
An elementary statistical description of the input and output
variables, in terms of median and range of the numeric variables
and the distributions of the categorical variables are shown in Ta-
ble 2 and Table 3. For more detailed description of each variable,
see Section 4.1.1.
4. Methods
4.1. Standard fuzzy system design
A standard (type-1) fuzzy system to recommend chemotherapy
treatment based on the clinical guidelines above was created. The
four main interconnected components used to generate a fuzzy
system are the input fuzziﬁer, the rule base, the inference engine,
and the output processor (defuzziﬁer) [24]. In the following, we de-
scribe how each part of the standard fuzzy system for breast cancer
treatment recommendation was constructed.
4.1.1. Input and output variable determination
As described above, ﬁve input variables and one output variable
were selected. By referencing the parameters provided in the
guidelines given in Table 1, the terms of each of the fuzzy variables
and their associated membership functions were carefully deter-
mined. In our research, either triangular or trapezoidal member-
ship functions were used for all of the fuzzy terms, since this
made it straight-forward to determine the intersection points be-
tween different membership functions. Triangular membership
functions are described by the notation (l,m, r) corresponding to
the left vertex, middle vertex and right vertex of the triangle, while
trapezoidal membership functions are described by the notation
(a, b, c, d) corresponding to the left-base, left-top, right-top and
right-base vertex, respectively. The initial design of the fuzzy sets
within each of the ﬁve inputs and one output is detailed as follows:
(A) NPI (Nottingham Prognostic Index)
The value of NPI is calculated according to the size of the lesion;
the number of involved lymph nodes; and the grade of the tumor
[28]. Speciﬁcally speaking, the NPI is deﬁned as
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where S represents the size of the indexed lesion in centimeters, N
represents the number of lymph nodes involved: N = 0 for negative
nodes, N = 2 for 1 to 3 positive nodes, and N = 3 for 4 or more posi-
tive nodes; and G is the grade of tumor giving a score of 1 (better) to
3 (worse).
It can be seen from the clinical guidelines that there are four
ranges of NPI values, namely NPI 6 3.0, NPI 2 [3.1, 3.4], NPI 2
[3.4, 4.4] and NPI > 4.4. Four fuzzy terms associated with these
ranges are designed as Low, Medium Low, Medium High, and High,
respectively. The universe of discourse of NPI was set to be
[0, 10]. The parameters of the four membership functions of the
initial NPI fuzzy sets were set to be:
 Low: (0, 0, 2.8, 3.2).
 Medium Low: (2.8, 3.2, 3.6).
 Medium High: (2.9, 3.9, 4.9).
 High: (3.9, 4.9, 10, 10).
Hence, Low intersects Medium low at 3.0, Medium low intersects
Medium High at 3.4, and Medium High intersects High at 4.4. The
initial NPI membership functions are shown in Fig. 3(a).
(B) ER (Estrogen Receptor Status)
A positive ER score gives an indication that estrogen is causing
the tumor to grow, and that the cancer should respond well to hor-
mone suppression treatments. A negative ER score means that the
tumor is not driven by estrogen, so other tests, such as HER2 status,
are needed to determine the most effective treatment. ER is over-
expressed in around 70% of breast cancer cases, referred to as
‘ER-positive’.
The universe of discourse of the estrogen receptor status is de-
ﬁned clinically as [0, 300]. From the guidelines three terms for ER
were apparent, namely ‘‘negative’’, ‘‘weak’’ and ‘‘positive’’. These
terms had clearly deﬁned, crisp clinical cut-offs of 20 (being the
cut-off between ‘‘negative’’ and ‘‘positive’’) and 100 (being the
upper cut-off for ‘‘weak’’) and were associated directly with the
fuzzy terms Negative, Weak and Positive. The parameters of the
three membership functions of the ER fuzzy sets were set to be:Table 4
Fuzzy rules derived directly from the clinical guidelines.
Rule Antecedent Consequent
1 IF (NPI is Low) THEN (Chemo is
No)
2 IF (NPI is Medium low) and (ER is not Negative) THEN (Chemo is
No)
3 IF (NPI is Medium low) and (ER is Negative) THEN (Chemo is
Maybe)
4 IF (NPI is Medium high) and (ER is not Negative) THEN (Chemo is
No)
5 IF (NPI is Medium high) and (ER is Negative) THEN (Chemo is
Yes)
6 IF (NPI is High) and (ER is not Negative) THEN (Chemo is
Maybe)
7 IF (NPI is High) and (ER is not Negative) and (Age
is Young)
THEN (Chemo is
Yes)
8 IF (NPI is High) and (ER is not Negative) and (VI is
Yes)
THEN (Chemo is
Yes)
9 IF (NPI is High) and (ER is Weak) THEN (Chemo is
Yes)
10 IF (NPI is High) and (ER is not Negative) and (Age
is Old)
THEN (Chemo is
No)
11 IF (NPI is High) and (ER is not Negative) and (LN is
Negative)
THEN (Chemo is
No)
12 IF (NPI is High) and (ER is Negative) THEN (Chemo is
Yes) Negative: (0, 0, 40).
 Weak: (0, 40, 160).
 Positive: (40, 160, 300, 300).
Hence, Negative intersects Positive at 20, while Weak reaches a
membership of 0.5 at 100. The ER membership functions are
shown in Fig. 3b.
(C) Age
The maximum age within our dataset was 88. From the guide-
lines, in which cut-offs of 40 and 60 can be seen, three fuzzy terms
were readily apparent: Young, Middle Aged, and Old. The parame-
ters of the three membership functions of the Age fuzzy sets were
set to be:
 Young: (0, 0, 30, 50).
 Middle age: (30, 50, 70).
 Old: (50, 70, 90, 90).
Hence, Young intersects Middle Aged at 40, while Middle Aged
intersects Old at 60. The Age membership functions are shown in
Fig. 3c.
It should be noted that the three terms – Young, Middle Aged,
and Old are just the universal linguistic terms used for describing
human age. It does not mean that breast cancer for the persons
aged less than 15 (for example) would be as frequent as ones aged
30s to 40s.
(D) VI (Vascular Invasion)
The presence of VI is generally considered to be an adverse fea-
ture providing independent prognostic information about both lo-
cal recurrence and survival. VI is determined according to
guidelines of the Royal College of Pathologists [30]: the presence
of unequivocal tumor in vascular spaces is recorded as VI ‘Yes’; if
there is doubt, but it is considered to be likely, it is recorded as
‘Maybe’; and if deﬁnitely not present it is recorded as ‘No’.
The VI is a categorical variable. The three categorical values of
vascular invasion, No, Maybe and Yes, were each associated with
a fuzzy term. The parameters of the three membership functions
of the VI fuzzy sets were set to be:
 No: (1, 1, 3).
 Maybe: (0.75, 2, 3.25).
 Yes: (1, 3, 3).
The initial VI membership functions are shown in Fig. 3d.
(E) LN (Positive Lymph Node Ratio)
During surgery, patients have some lymph node samples taken
in order for further analysis to be performed. For example, ten
lymph nodes may be taken, for which subsequent analysis identi-
ﬁes that eight of the nodes are positive and two of the nodes are
negative (for cancerous changes). In the guidelines provided, when
NPI is greater than 4.4 and ER is positive, the recommendation will
be against chemotherapy when there is only one positive lymph
node found. However, in the given clinical data, the number of
lymph nodes taken from patients varied from 0 to 43, and the
number of positive lymph nodes found varied from 0 to 40. So,
‘‘there is only 1 lymph node positive’’ would apply equally to a pa-
tient with one positive out of one taken, and to one positive out
of 40 taken.
In order to allow a fuzzy interpretation of this variable, the ratio
of the number of positive lymph nodes to the number of lymph
nodes taken was used as the input value for the LN variable. Note
that there is no clear clinical justiﬁcation for using lymph node po-
sitive ratio, as opposed to simply the number of positive lymph
(a) NPI (b) ER
(c) Age (d) VI
(e) LN (f) Chemo
Fig. 3. Initial membership functions for the fuzzy variables.
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tion of the LN variable. In the data, for the cases in which there is
only one positive lymph node, the value of LN lies within a range
[1/36, 1/1], or roughly [0.03, 1]. From this, the universe of discourse
was set as [0, 1]. Two fuzzy terms were created, corresponding to
Negative and Positive. The parameters of the two membership func-
tions of the LN fuzzy sets were set to be:
 Negative: (0, 0, 0.04).
 Positive: (0, 0.2, 1, 1).
Hence, Negative intersects Positive at approximately 0.03, corre-
sponding to a lymph node ratio of 1 in 36. The initial LN member-
ship functions are shown in Fig. 3e.
(F) Chemotherapy (Chemo)
The output for the fuzzy system, Chemo, represents the recom-
mendation in favor of or against chemotherapy adjuvant treatment.
It should be noted that the recommendation made by the clinician
in the MDT may not correspond to the treatment that was ﬁnally
administered (as a patient may decide against receiving a recom-
mendation, such as chemotherapy, even if it is strongly recom-
mended by the clinician). The variable contains three possible
outcomes: Yes (corresponding to a recommendation for chemother-
apy), No (corresponding to a recommendation against chemother-
apy) and Maybe (corresponding to a recommendation to discuss
or consider chemotherapy). If the recommendation is ‘‘no adjuvant
treatment’’ or ‘‘recommend hormone therapy’’, it was considered as a
recommendation ‘‘against chemotherapy’’ for this study. The cate-
gory of ‘‘Maybe’’ is used, because the clinical free-text commentsshowed that for some breast cancer cases, the MDT did not
make clear recommendations like ‘‘recommend chemotherapy’’,
instead, recommendations like ‘‘discuss chemotherapy’’, ‘‘possible
chemotherapy’’ were made. In these cases, the patients might not
prefer chemotherapy treatment, or the chemotherapy might help to
reduce the risk of the cancer coming back but certainly was not
the optimal way of treatment. So we treated these decisions as an
additional treatment plan – ‘‘Maybe’’.
The universe of discourse of the Chemo variable was set as
[0, 100]. From observation of the actual recommendations in the
database, it was found that many fewer cases appear in the Maybe
category compared to either Yes or No categories. Therefore in the
membership function design,Maybewas created to occupy a much
narrower range than the other two. By a process of manual tuning,
the cut-off points between these three options was found to
achieve the best results when Maybe occupied a range around
[55, 57]. Based on these ﬁndings, the three membership functions
of the fuzzy sets for the Chemo output variable were set to be:
 No: (0, 0, 54, 56).
 Maybe: (55, 55, 57).
 Yes: (55, 57, 100, 100).
Hence, No intersects Maybe at 55, and Maybe intersects Yes at
56. The initial Chemo membership functions are shown in Fig. 3f.
4.1.2. Fuzzy rules
As the rules are the elements which deﬁne the relationship be-
tween the input and the output variables, the generation of a set of
trustworthy rules is the key to producing a good quality fuzzy
Table 5
An example of a confusion matrix of decision agreement.
Decision by fuzzy system Clinician decision
No Maybe Yes
No 1000 37 72
Maybe 2 3 4
Yes 65 12 115
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from the knowledge of human experts (knowledge-driven) or ex-
tracted from an existing database (data-driven). In this paper, we
used the ﬁrst method to derive the rules since the clinical guide-
lines provided by the Nottingham University Hospitals NHS Trust
provide a formal framework for clinical decision making in this
context. Hence, a set of fuzzy rules were derived directly from
these guidelines, as shown in Table 4.4.1.3. Fuzzy inference method
The fuzzy decision making process is implemented using a con-
ventional Mamdani style fuzzy inference system. The usual min
and max operators are used for conjunction and disjunction,
respectively, and also for implication and aggregation, respectively.
Centroid (centre-of-gravity) defuzziﬁcation is used to obtain the
crisp output of fuzzy inference.4.1.4. Output processing
The ﬁnal step is to convert the crisp value obtained from the
fuzzy inference system into a categorical agreement in the set
{No,Maybe, Yes}. The crisp value was compared to the ﬁxed inter-
section points of the No, Maybe and Yes membership functions of
the Chemo variable. The intersection of No and Maybe occurs at
55, while the intersection of Maybe and Yes occurs at 56, as de-
scribed above. Hence, the label of No, Maybe or Yes is assigned
according to whether the crisp value obtained through defuzziﬁca-
tion falls in the interval [0, 55], (55, 56] or (56, 100], respectively.
Finally, in order to compare the performance of the fuzzy system
against the actual decisions recommended in clinical practice, an
agreement confusion matrix is generated; an example is shown
in Table 5. In this paper, the absolute categorical agreement is(a) NPI
(c) VI
Fig. 4. Alternative membership functions forused: for instance, in the example shown in Table 5, the agreement
is:
P3
i¼1Ci;iP3
i;j¼1Ci;j
¼ 1000þ 3þ 115
1310
¼ 85:34%4.2. Fuzzy model design using non-stationary fuzzy sets for breast
cancer treatments
There were two main mechanisms used to explore the effects of
alternative fuzzy models in this decision making scenario. Firstly,
the choice of alternative membership functions and, secondly,
the introduction of various amounts of variability into the infer-
ence through the use of non-stationary fuzzy sets. The selection
of the set of input variables, the membership functions of all asso-
ciated terms, the fuzzy rules and the amount (and nature) of vari-
ability to be incorporated in the non-stationary fuzzy sets within
the system is collectively referred to as the selection of the ‘fuzzy
model’. The speciﬁcation of the membership functions of all the
terms is, thus, one component of the fuzzy model. In this paper
we use the term ‘fuzzy foundation’ or just ‘foundation’ to refer to
the selection of membership functions.
4.2.1. Alternative foundations
The use of alternative membership functions was explored
through the determination of an alternative set of membership
functions for four of the ﬁve input variables, namely NPI, Age, VI
and LN. The ER variable was not altered as its points of intersection
were ﬁxed by the presence of accepted clinical thresholds (at 20
and 100): they were so well established that alteration of the
membership functions would be clinically counter-intuitive. Alter-
native forms for the membership functions for four variables were
variously combined to give 16 foundations. The parameters of the
alternative membership functions are given below, and the resul-
tant membership functions are illustrated in Fig. 4.
(A) NPI
The parameters of the four membership functions of the alter-
native fuzzy sets for NPI were set to be:
 Low: (0, 0, 2.6, 3.4).(b) Age
(d) LN
the NPI, Age, VI and LN input variables.
Table 6
The notation used to describe each foundation system.
Foundation
name
Description
Original–F Original foundation
NPI–F Only NPI use the new membership function setting
Age–F Only Age use the new membership function setting
VI–F Only VI use the new membership function setting
LN–F Only LN use the new membership function setting
NPI–Age–F Only NPI and Age use the new membership function
setting
NPI–VI–F Only NPI and VI use the new membership function setting
NPI–LN–F Only NPI and LN use the new membership function
setting
Age–VI–F Only Age and LN use the new membership function
setting
Age–LN–F Only VI and LN use the new membership function setting
VI–LN–F Only VI and LN use the new membership function setting
Age–NPI–LN–F Only LN does not use the new membership function
setting
Age–VI–LN–F Only VI does not use the new membership function
setting
NPI–VI–LN–F Only Age does not use the new membership function
setting
Age–NPI–VI–F Only NPI does not use the new membership function
setting
Age–VI–LN–
NPI–F
All four inputs use the new membership function setting
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 Medium high: (3.5, 3.4, 5.4).
 High: (4.4, 4.4, 10, 10).
The intersection points remain the same as for the initial mem-
bership functions.Fig. 5. Pseudo code of the proposed methodology for(B) Age
The parameters of the three membership functions of the alter-
native fuzzy sets for Age were set to be:
 Young: (0, 0, 35, 45).
 Middle age: (35, 45, 55, 65).
 Old: (55, 65, 90, 90).
The intersection points remain the same as for the initial mem-
bership functions.
(C) VI (Vascular Invasion)
The parameters of the three membership functions of the alter-
native fuzzy sets for VI were set to be:
 No: (0, 1, 2).
 Maybe: (1, 2, 3).
 Yes: (2, 3, 4).
The intersection points remain the same as for the initial mem-
bership functions.
(D) LN (Number of Positive Lymph Nodes)
The parameters of the two membership functions of the alter-
native fuzzy sets for LN were set to be:
 Negative: (0, 0, 0.2).
 Positive: (0, 0.2, 1, 1).
Hence, Negative now intersects Positive at 0.1, corresponding to
a lymph node ratio of 1 in 10, rather than 1 in 36. We use ‘NPI-F’ tocreating a non-stationary fuzzy inference system.
Table 7
The agreements obtained by the non-stationary fuzzy models for a range of r vs those
obtained by each foundation system without perturbations. The best result for each
foundation is highlighted in bold.
Foundation name r in perturbation function
None 0.01 0.02 0.03 0.04 0.05 0.06
Original–F 84.58 85.42 87.25 87.94 88.02 88.09 87.86
NPI–F 84.12 85.57 87.25 87.56 87.71 87.71 88.02
Age–F 84.89 85.88 87.63 88.02 88.17 88.17 88.24
VI–F 83.28 85.27 87.71 87.86 87.79 87.94 87.86
LN–F 82.98 85.19 87.02 87.56 87.71 87.79 87.71
NPI–Age–F 85.50 85.95 87.56 88.09 87.94 88.09 87.86
NPI–VI–F 84.96 85.50 87.25 87.63 87.63 87.71 87.63
NPI–LN–F 84.89 85.50 87.10 87.79 87.79 87.56 88.17
Age–VI–F 84.73 85.95 87.56 88.17 88.09 88.02 88.02
Age–LN–F 84.66 85.73 87.48 87.86 88.24 88.24 88.17
VI–LN–F 84.20 85.27 87.48 87.79 87.56 87.86 88.02
Age–NPI–LN–F 85.27 85.95 88.02 88.02 88.24 88.09 88.09
Age–VI–LN–F 84.50 85.95 87.71 87.71 88.09 88.63 88.17
NPI–VI–LN–F 84.73 85.34 87.48 87.48 87.63 87.71 87.63
Age–NPI–VI–F 85.34 85.80 87.40 88.09 88.24 88.17 87.94
Age–VI–LN–NPI–F 85.11 85.88 87.71 88.02 88.09 88.02 88.09
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ship functions and the remainder of the variables are as the origi-
nal. The list of foundation names and their descriptions are shown
in Table 6. Obviously there are many other alternative foundations
that are available for selection. The use of automated tuning meth-
odologies such as the ANFIS approach [2], or heuristic tuning meth-
ods such as genetic algorithms (e.g. [8]) and simulated annealing
(e.g. [33]), will explore the range of alternative membership func-
tions further, but all require the system to be trained against a spe-
ciﬁc reference set of cases.
4.2.2. Alternative variability
The purpose of this paper is to evaluate the effects of incorpo-
rating variability into a real-world decision making scenario,
through the mechanism of the non-stationary fuzzy sets intro-
duced by Garibaldi [24]. In his original paper, Garibaldi describes
different types of non-stationarity (e.g. by shifting membership
functions left-right or up-down), different forms of perturbation
function (e.g. generating random, sinusoidal or chaotic variations)
and different sizes (amounts) of variation. In this study, we restrict
the perturbations investigated to shifts in membership function
location (i.e. left-right shifts), using normally distributed random
perturbations (with mean zero). Only the amount of variation, gov-
erned by the standard deviation (r) of the normally distributed
perturbations, was varied. As the standard deviation is relative to
the universe of discourse of each variable, a standard deviation of
(for example) 0.01 corresponds to a variation of 1/100th of the uni-
verse of discourse.
Once the standard deviation has been set, and the foundation
fuzzy system has been selected, a complete iteration consists of
randomly perturbing the membership functions of all variables
and then running the resultant fuzzy inference system (termed
an instantiation of the system) on all the 1310 cases in our data-
base. The fuzzy system for each instantiation will therefore obtain
an agreement percentage for the 1310 cases. The average of the
agreement percentages from all the instantiations of each founda-
tion can then also be calculated. The complete procedure is de-
scribed in the pseudo code in Fig. 5.
4.3. Fuzzy model tuned by ANFIS
As a comparison, the ANFIS approach was also used to tune a
fuzzy inference system based on the same clinical data. An ANFIS
system constructs a Takagi-Sugeno type fuzzy inference model inpractice. In contrast to Mamdani type fuzzy inference systems as
described above, the consequent parts of Takagi-Sugeno fuzzy
rules are local linear functions or constants. The overall output of
the system is the three recommendations of Chemo: No, Maybe
and Yes.5. Results
The performances of the designed fuzzy decision support sys-
tems were evaluated in terms of the rates of agreements with
the decisions made by clinicians. Each foundation system consists
of 12 fuzzy rules as described in Table 4, but the fuzzy sets used in
different foundation systems have different settings. The second
column of Table 7 summarizes the results of each foundation
system without perturbations. The level of agreement with clini-
cian’s decision generally increases with the use of the alternative
membership functions, and the best overall performance (without
perturbations) was obtained by the NPI–Age–F system (i.e. the
system featuring only alternative NPI and Age membership
functions).
We then applied perturbations to each foundation system on a
range of settings for r over 1000 iterations. The value of r was set
to be 0.01, 0.02, 0.03, 0.04, 0.05 and 0.06 separately. The best
agreements obtained for each foundation system have been identi-
ﬁed in bold in Table 7. Through perturbations, the best perfor-
mance of non-stationary fuzzy systems reached a mean of
around 88.09% agreement in breast cancer treatment recommen-
dations (p < 0.001, 95% CI: 87.96–88.21%). It can be seen from Table
7 that hardly any performance gain was achieved with small per-
turbations, particularly 0.01, and that the best performance was
usually obtained at around 0.05 variation. While we do not believe
this result can be generalized, it may support the idea that very
small variations are unlikely to lead to any performance gains.
As a comparison, ANFIS was also used to tune a fuzzy inference
system based on the same clinical data. From the whole data set,
800 cases were randomly chosen as training data and the remain-
ing 510 cases as the testing data. The total number of parameters
that need to be trained was 261 (including 216 linear and 45 non-
linear parameters) and the number of generated fuzzy rules was
216. The agreement rate of tuned fuzzy model applied to testing
cases is 85.88%. Fig. 6 shows the corresponding membership func-
tions generated by the ANFIS. It can be seen that our constructed
fuzzy inference system can achieve performance comparable to
the ANFIS fuzzy model. Importantly, the membership functions
generated by the ANFIS method suffer from poor interpretation,
particularly the NPI and LN fuzzy sets whose membership func-
tions could not be well interpreted according to the clinician
knowledge as described in the clinical protocol. On the other hand,
the ANFIS fuzzy model generated a rule-base with 216 rules (cov-
ering all the combinations of the terms of the input variables),
these fuzzy rules do not match the clinical guidelines in practice.
Considering the fact that our proposed fuzzy inference model only
uses 12 fuzzy rules to make breast cancer treatment recommen-
dation, our proposed model achieves much better parsimony in
model construction and better model interpretability than the
ANFIS model in making breast cancer treatment recommen-
dations.
In terms of the detailed decision making, we examined the con-
fusion matrices for the original foundation system and a represen-
tative of the mean best performing of the non-stationary systems.
The confusion matrices for the original foundation (1108 agree-
ments, 84.58%) and the mean best non-stationary system (1154
agreements, 88.09%) are given in Table 8. It can be seen that the
best non-stationary system increases the overall number of agree-
ments while increasing both true negatives and true positives.
(a) NPI (b) ER
(c) Age (d) VI
(e) LN
Fig. 6. Tuned input membership functions from ANFIS.
J.M. Garibaldi et al. / Journal of Biomedical Informatics 45 (2012) 447–459 4576. Discussion
Making predictions in individuals under uncertainty has be-
come a critical activity in healthcare [9]. From the perspective of
biomedical informatics, an important way of assisting healthcare
providers in making decisions under uncertainty is to develop for
them computer manageable decision models with good interpreta-
tion and predictive performance. Fuzzy models constructed by aset of easily understandable if–then rules have become a popular
choice for incorporating human knowledge into problem solving
process under uncertainty. In this paper, we have shown how we
have taken into account a clinical protocol and successfully repre-
sented the decision making under uncertainty within a fuzzy infer-
ence system. The initial linguistic terms expressed by fuzzy sets
were used with a standard fuzzy system to capture the essential
knowledge encoded within a clinical protocol and associated
Table 8
The confusion matrices corresponding to the original system and a representative
result from the best non-stationary systems.
Fuzzy system
decision
Clinical decision Fuzzy system
decision
Clinical decision
No Maybe Yes No Maybe Yes
(a) The original system confusion
matrix
(b) The best non-stationary confusion
matrix
No 982 35 64 No 1011 30 49
Maybe 2 2 3 Maybe 3 4 3
Yes 83 15 124 Yes 53 18 139
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cancer treatment recommendations with an overall agreement to
clinical practice of 84.58%. By interactively tuning a range of alter-
native membership functions which retained the essential crisp
clinical thresholds, the performance of the system could be in-
creased further to 85.50%.
As part of ongoing research into incorporating variability into
fuzzy inference, in order to permit ensemble decision making, re-
sults in this paper demonstrate that introducing random left-right
shifts of the membership functions (alterations in the location of
the membership functions) can signiﬁcantly increase the system
performance further to around 88.09% (95% CI: 87.96–88.21%,
p < 0.001). In this way, it may be possible that an effective fuzzy
inference system can be designed without any tuning, simply by
creating a reasonable foundation system, applying a small varia-
tion and by creating effective ensemble decision making.
The use of fuzzy inference systems to model expert decision
making (in clinical or other contexts) is a pragmatic approach in-
tended to simulate the results of human reasoning. It does not
mean that the modeler is making any assumption that fuzzy infer-
ence is somehow taking place inside the expert’s brain. Similarly,
using randomly generated non-stationary fuzzy sets to model ex-
pert variability does not imply any assumption on the origin of
such variability. The non-stationary approach adopted in this pa-
per models two situations simultaneously: (i) the inter-expert var-
iability exhibited in any panel of experts, and (ii) the intra-expert
variability exhibited in any single expert (that is not attributable
to learning). While these two underlying causes of variability are
obviously completely different, they are both implicitly modeled
in our approach. As an aside, we note that the permanent alteration
of fuzzy membership functions, such as is the case in a ‘conven-
tional’ ANFIS approach (see Section 3.4), is more akin to the process
of learning, which may be deﬁned in a Pavlovian sense as a perma-
nent change in stimulus–response (input–output) mapping.
In summary, based on our research in this paper, a trustworthy
procedure for designing an effective non-stationary fuzzy system
for decision recommendation can include the following steps:
(1) create a reasonable (acceptable) static fuzzy inference
system;
(2) incorporate variability into the membership functions to
obtain alternative decisions (tentatively, variability of
around 5% variation in location may be suitable);
(3) run the inference system multiple times to obtain a range of
alternative acceptable decisions; and
(4) employ ensemble techniques to recommend the set of the
best from the range of alternatives.
This is a new approach to fuzzy inference system design, com-
plementary to other standard approaches. While not necessarily
any better than any other approach, our method may be generally
applicable to a wide range of applications.7. Conclusions and future work
In this paper, we have presented a methodology of designing
effective non-stationary fuzzy inference systems for breast cancer
treatment recommendations. Our research demonstrated that
incorporating variability into a conventional fuzzy inference sys-
tem can enhance the decision making of that system.
Further study of representing intra- and/or inter-expert varia-
tion within fuzzy inference systems is being conducted. The deci-
sions by a number of clinical experts on a subset of the same
group of cases are currently being collected over a sequence of
time. This will allow the variability introduced into the fuzzy infer-
ence system described here to be compared directly to the variabil-
ity observed in real clinical experts. For the decisions made from a
group of medical experts, a consensus model will be generated so
that the ﬁnal decision can be most representative of the opinions of
the multidisciplinary panel. To this end, a new type of operator
that is able to aggregate the decisions modeled by fuzzy sets with
variability into an overall one is needed. The type-1 OWA operators
and type-2 OWA operators [31–33] could beneﬁt this research.
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